9-hydroxy-10,12-octadecadienoic acid

Subscribe to Selected New Research on 9-hydroxy-10,12-octadecadienoic acid

4 relevant articles (0 outcomes, 0 trials/studies) found for this Bio-Agent

Description: RN given refers to unspecified stereoisomer

Also Known As:

9-HODE; 9-OH-18:2delta(10t,12t); 9-hydroxy-10,12-octadecadienoic acid, (E,E)-(+-)-isomer; 9-hydroxy-10,12-octadecadienoic acid, (E,E)-isomer; 9-hydroxy-10,12-octadecadienoic acid, (E,Z)-(+-)-isomer; 9-hydroxy-10,12-octadecadienoic acid, (E,Z)-isomer; 9-hydroxy-10,12-octadecadienoic acid, (R-(E,Z))-isomer; 9-hydroxy-10,12-octadecadienoic acid, (S-(E,Z))-isomer; 9-hydroxylinoleic acid; dimorphecolic acid; 10,12-octadecadienoic acid, 9-hydroxy-

Bio-Agent Context: Research Results

Lipids: 13330

Fatty Acids: 4673

Unsaturated Fatty Acids: 2227

Omega-6 Fatty Acids: 174

Linoleic Acids: 42

Conjugated Linoleic Acids: 37

9-hydroxy-10,12-octadecadienoic acid: 4

Related Diseases

1.	Hemorrhagic Shock 09/01/1998 - "Strong increase of 9-hydroxy-10,12-octadecadienoic acid in low density lipoprotein after a hemorrhagic shock." Order ALL the reference details at left...
2.	Papilloma (Papillomatosis) 02/01/1999 - "As compared with normal epidermis, papillomas exhibited 25- and 4-fold elevated levels of 8-HETE and 9-HODE, respectively" Order ALL the reference details at left...
3.	Neoplasms (Cancer) 09/15/1999 - "The addition of 13-HODE to the nordihydroguaiaretic acid-containing whole blood perfusate increased the rate of [3H]thymidine incorporation 10 times and nearly doubled tumor DNA content; the addition of 13-KODE or 9-HODE had no effect" Order ALL the reference details at left...
4.	Inflammation 05/30/1997 - "The genesis of 9- and 13-HODE seems therefore to be an important factor in the development and progression of rheuma; in addition 9-HODE was reported to be a stimulus of inflammation, comparable to leukotrienes." Order ALL the reference details at left...
5.	Rheumatoid Arthritis 05/30/1997 - "9-Hydroxy-10,12-octadecadienoic acid (9-HODE) and 13-hydroxy-9,11-octadecadienoic acid (13-HODE) are accumulated in the low density lipoproteins of patients suffering from rheumatoid arthritis for a factor of 20-50 compared to healthy individuals of the same age" Order ALL the reference details at left...

Related Drugs and Biologics

1.	13-hydroxy-9,11-octadecadienoic acid
2.	Leukotrienes
3.	Thymidine
4.	Nordihydroguaiaretic Acid (Masoprocol)
5.	LDL Lipoproteins (beta Lipoproteins)
6.	Lipoproteins (Lipoprotein)
7.	DNA (Deoxyribonucleic Acid)
8.	8-hydroxyeicosatetraenoic acid
9.	A-factor (Streptomyces)

Best Treatments:
Research Summary Report
on Hemorrhagic Shock

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 221 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>